In the future, a more differentiated consideration of the activity criterion of subretinal fluid in vPED due to AMD by means of enhanced imaging modalities seems reasonable, particularly with regard to an optimal anti-VEGF treatment strategy. This evidence concerns the gene VEGFA and age-related macular degeneration.